A Multicenter Open-labeled Pilot Study on Recombinant Human Thrombopoietin in Management of Immune Thrombocytopenia in Pregnancy
Phase of Trial: Phase III
Latest Information Update: 06 Dec 2016
At a glance
- Drugs Thrombopoietin (Primary)
- Indications Immune thrombocytopenic purpura
- Focus Adverse reactions; Therapeutic Use
- 06 Dec 2016 Results assessing efficacy and safety presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
- 18 Apr 2016 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.
- 18 Apr 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.